Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

Linear Clinical Research

Nedlands, AusztráliafacilityHonlap

66futó vizsgálat
23lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Toboroz
Evaluation of XYA02 in Patients With Advanced Solid Tumors
NCT07670312· 1/2. fázis· Forrás
Toboroz
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
NCT07545122· 1. fázis· Forrás
Toboroz
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
NCT07713732· 1. fázis· Forrás
Toboroz
A Study of ARC-02 in B-cell NHL
NCT07691606· 1. fázis· Forrás
Toboroz
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328· 1. fázis· Forrás
Toboroz
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
NCT07441694· 1. fázis· Forrás
Toboroz
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
NCT07249905· 1/2. fázis· Forrás
Toboroz
A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy Participants
NCT07532655· 1. fázis· Forrás
Toboroz
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary Disease
NCT07285122· 1. fázis· Forrás
Toboroz
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07435038· 1/2. fázis· Forrás
Toboroz
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
NCT07334119· 1. fázis· Forrás
Toboroz
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
NCT07244705· 1/2. fázis· Forrás
Toboroz
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
NCT07008118· 1. fázis· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187· 3. fázis· Forrás
Toboroz
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012· 3. fázis· Forrás
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· 3. fázis· Forrás
Toboroz
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798· 2. fázis· Forrás
Fut, nem toboroz
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
NCT06830850· 1. fázis· Forrás
Toboroz
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
NCT06944925· 1. fázis· Forrás
Toboroz
A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
NCT06917742· 1. fázis· Forrás
Toboroz
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
NCT06756932· 1. fázis· Forrás
Toboroz
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172· 1. fázis· Forrás
Toboroz
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
NCT06697184· 1/2. fázis· Forrás
Meghívásos bevonás
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509· 1. fázis· Forrás
Fut, nem toboroz
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
NCT06679985· 2. fázis· Forrás
Toboroz
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
NCT06597721· 1. fázis· Forrás
Toboroz
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775· 2. fázis· Forrás
Toboroz
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048· 3. fázis· Forrás
Toboroz
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
NCT06478693· 1. fázis· Forrás
Toboroz
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069· 1. fázis· Forrás
Toboroz
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314· 3. fázis· Forrás
Toboroz
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
NCT06366789· 1. fázis· Forrás
Toboroz
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
NCT06343402· 1. fázis· Forrás
Fut, nem toboroz
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
NCT06205628· 1. fázis· Forrás
Toboroz
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT06244771· 1/2. fázis· Forrás
Toboroz
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827· 1/2. fázis· Forrás
Toboroz
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221· 1/2. fázis· Forrás
Toboroz
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
NCT06179160· 1. fázis· Forrás
Toboroz
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012· 1. fázis· Forrás
Toboroz
IKS014 in Advanced Solid Tumors That Express HER2
NCT05872295· 1. fázis· Forrás
Fut, nem toboroz
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
NCT05919537· 1. fázis· Forrás
Toboroz
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659· 1. fázis· Forrás
Fut, nem toboroz
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
NCT05907304· 1. fázis· Forrás
Toboroz
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
NCT05969041· 1. fázis· Forrás
Fut, nem toboroz
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
NCT05878184· 1. fázis· Forrás
Fut, nem toboroz
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879· 1. fázis· Forrás
Fut, nem toboroz
Study to Assess SLN124 in Patients With Polycythemia Vera
NCT05499013· 1/2. fázis· Forrás
Fut, nem toboroz
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552· 1/2. fázis· Forrás
Fut, nem toboroz
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
NCT05581004· 1. fázis· Forrás
Toboroz
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
NCT05519449· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
A Trial of HRS-1893 in Healthy Volunteers
NCT07033455· Korai 1. fázis· Forrás
Toboroz
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
NCT06808477· 1. fázis· Forrás
Leállították
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
NCT06585488· 1. fázis· Forrás
Lezárult
A Study of TeriQ Patch in Healthy Adult Female Participants
NCT06644040· 1. fázis· Forrás
Lezárult
Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers
NCT06780124· 1. fázis· Forrás
Lezárult
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
NCT06326060· 2. fázis· Forrás
Lezárult
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
NCT05665530· 1. fázis· Forrás
Leállították
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
NCT05828589· 1. fázis· Forrás
Lezárult
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
NCT05583552· 2. fázis· Forrás
Leállították
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NCT05252390· 1. fázis· Forrás
Lezárult
A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
NCT04657224· 1. fázis· Forrás
Lezárult
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
NCT04670679· 1. fázis· Forrás
Lezárult
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT04540796· 1. fázis· Forrás
Leállították
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
NCT04383210· 2. fázis· Forrás
Lezárult
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
NCT04242199· 1. fázis· Forrás
Lezárult
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
NCT04526106· 1/2. fázis· Forrás
Lezárult
IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
NCT04109456· 1. fázis· Forrás
Lezárult
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
NCT04215978· 1. fázis· Forrás
Lezárult
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
NCT04052971· 1. fázis· Forrás
Lezárult
A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
NCT03900598· 1. fázis· Forrás
Lezárult
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
NCT03740529· 1/2. fázis· Forrás
Lezárult
A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
NCT03331731· 2. fázis· Forrás
Lezárult
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
NCT03674567· 1/2. fázis· Forrás

Vizsgálati helyszínek

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Köpenysejtes limfóma4 munka · 9 vizsgálat

Intézményadatok: ROR 05vnpr825 (CC0-1.0)Frissítve: 2026. nov. 10.

Építés alatt, nem éles – Linear Clinical Research: vizsgálatok és kutatócsoportok – Frontlight Research